Mukul Gupta, M.D., FACP
Investigator
Mukul Gupta, MD is a board-certified medical oncologist and hematologist at Sansum Clinic’s Ridley-Tree Cancer Center in Santa Barbara and Solvang, California, where he has been in practice since 2004. Dr. Gupta specializes in the diagnosis and treatment of cancer and blood disorders and has been actively involved in oncology clinical trials throughout his career.
He completed fellowships in medical oncology and hematology at LAC+USC Medical Center, serving as Chief Fellow and earning Teacher of the Year honors. He completed his internal medicine residency and internship at LAC+USC. He earned his medical degree from the University of Zambia and holds a bachelor’s degree in human biology with honors.
Dr. Gupta has contributed to multiple research studies and publications in oncology and hematology and is proficient in several languages, including Spanish, Hindi, and Nyanja.
Clinical trials
- Clinical trial
Adjuvant Colorectal Cancer Stage II/III ctDNA+ BNT122-01
A Multi-site, Open-label, Phase II, Randomized, Controlled Trial to Compare the Efficacy of RO7198457 Versus Watchful Waiting in Resected, Stage II (High Risk) and Stage III Colorectal Cancer Patients Who Are ctDNA Positive Following Resection
Status: Open to Enrollment
A Phase III, Open-label, Multi-center, Randomized Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive Metastatic Castration Resistant Prostate Cancer
Status: Open to Enrollment
- Clinical trial
Muscle-Invasive Bladder Cancer EV-309
A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO EVALUATE ENFORTUMAB VEDOTIN IN COMBINATION WITH PEMBROLIZUMAB IN ADULT PARTICIPANTS WITH MUSCLE-INVASIVE BLADDER CANCER WHO ARE INELIGIBLE FOR OR HAVE ELECTED NOT TO UNDERGO CYSTECTOMY
Status: Open to Enrollment